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ABSTRACT
Meningococcal disease has had devastating consequences in 
Northern Ireland since its first description locally in 1859.  The 
incidence of this disease has significantly declined in recent 
years, however it is important to understand reasons for this 
changing epidemiology and to acknowledge the diagnostic and 
clinical management developments that have been made locally. 
This review aims to examine the changing face of this disease in 
Northern Ireland over the years, with particular reference to local 
disease prevention, epidemiology, diagnosis, clinical treatment 
and management, post-disease sequelae and the role of meningitis 
charities locally, in terms of patient support and research.
BACKGROUND
In 2014, a forum named “MeningoNI” was established to 
bring together stakeholders with a professional interest in 
meningococcal disease in Northern Ireland.  MeningoNI offers a 
forum for education and discussion of matters with a broad interest 
in meningococcal disease, allowing key local stakeholders, the 
opportunity to consider recently evolving meningococcal disease 
in the context of detection and characterisation, microbial 
pathogenesis, epidemiology, disease prevention and vaccinology. 
Specific objectives of the Forum are:-
(a). To create a local (NI) Forum and meeting place for key 
stakeholders to consider evolving issues in meningococcal 
disease, 
(b). To independently consider existing and emerging scientific 
evidence relating to disease management,
(c). To consider the advice of expert National Committees in a 
devolved NI context,
(d). To consider the jurisdictional aspects of meningococcal 
disease detection and management on the Island of Ireland, 
given that NI is the only region of the UK to share a land 
border with another EU member State (Republic of Ireland),
(e). To issue independent advice/guidance as an expert forum on 
the strategic development of health systems in NI relating to 
meningococcal disease management/prevention, including 
charting a roadmap for optimum patient outcome in NI,
(f). To examine policy relating to meningococcal disease 
control, including meningococcal disease, between NI/
within the devolved nations of the UK, as well as with our 
neighbouring EU member State and to explore models of 
synergy and collaboration with these nations, to minimise 
the burden of meningococcal disease for all.
The Forum has met on numerous occasions and has involved 
key speakers from within and outside NI, including Professor 
Andrew Pollard, Chair, UK Joint Committee on Vaccination & 
Immunisation (JCVI), Professor Karina Butler, Chair, National 
Immunisation Advisory Committee, Dublin, as well as local 
MLAs, Stormont Health Committee, NI MPs and Dr Michael 
McBride, NI Chief Medical Officer. 
This review represents one output from this Forum and the 
authors trust that this will add value to those readers with 
an interest in meningococcal disease, locally, nationally and 
internationally. All authors are members of the Northern Ireland 
Meningococcal Stakeholders’ Forum (MeningoNI).
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